Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults
Clinical trial NCT05228314 · COMPLETED
Trial details
- NCT number
- NCT05228314
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2022-09-23
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.